Perceptive Advisors
PLXP

Perceptive Advisors’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Perceptive Advisors’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-57,459
Closed -$793K – 164
2021
Q2 		$793K Sell
57,459
-164,721
-74% -$1.95M 0.01% 145
2021
Q1 		$2.01M Buy
+222,180
New +$1.62M 0.03% 127

Other funds holding PLXP

MSD Partners
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Friess Associates
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
EAM Investors
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Perceptive Advisors's PLXP Position: Q3 2021 in Review

Perceptive Advisors sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2021, closing a stake of 57,459 shares — an estimated $793K sold.

Perceptive Advisors first reported a position in PLXP in Q1 2021 and held it in 2 quarters. The position peaked at $2.01M in Q1 2021. 63 funds tracked by Wall St. Rank hold PLXP as of Q3 2021.

  • Perceptive Advisors reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Perceptive Advisors sold 57,459 PLx Pharma Inc. Common Stock shares in Q3 2021, an estimated $793K.
  • Perceptive Advisors first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Perceptive Advisors's PLx Pharma Inc. Common Stock position peaked at $2.01M in Q1 2021.
  • 63 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2021.

Based on Perceptive Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.